Oncorus, Inc is a biotechnology business based in the US. Oncorus shares (ONCR) are listed on the NASDAQ and all prices are listed in US Dollars. Oncorus employs 56 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Oncorus
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ONCR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Oncorus stock price (NASDAQ: ONCR)Use our graph to track the performance of ONCR stocks over time.
Oncorus shares at a glance
|Latest market close||$17.20|
|52-week range||$11.50 - $37.86|
|50-day moving average||$15.01|
|200-day moving average||$17.53|
|Wall St. target price||$37.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Buy Oncorus shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Oncorus stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Oncorus price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||15.05%|
|3 months (2021-04-28)||3.93%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-19.92%|
|Return on equity TTM||-48.62%|
|Market capitalisation||$339.8 million|
TTM: trailing 12 months
Shorting Oncorus shares
There are currently 1.2 million Oncorus shares held short by investors – that's known as Oncorus's "short interest". This figure is 21.8% up from 1.0 million last month.
There are a few different ways that this level of interest in shorting Oncorus shares can be evaluated.
Oncorus's "short interest ratio" (SIR)
Oncorus's "short interest ratio" (SIR) is the quantity of Oncorus shares currently shorted divided by the average quantity of Oncorus shares traded daily (recently around 214209.26573427). Oncorus's SIR currently stands at 5.72. In other words for every 100,000 Oncorus shares traded daily on the market, roughly 5720 shares are currently held short.
To gain some more context, you can compare Oncorus's short interest ratio against those of similar companies.
However Oncorus's short interest can also be evaluated against the total number of Oncorus shares, or, against the total number of tradable Oncorus shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Oncorus's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Oncorus shares in existence, roughly 50 shares are currently held short) or 0.1212% of the tradable shares (for every 100,000 tradable Oncorus shares, roughly 121 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Oncorus.
Find out more about how you can short Oncorus stock.
Oncorus share dividends
We're not expecting Oncorus to pay a dividend over the next 12 months.
Oncorus, Inc. , a clinical stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. Oncorus, Inc. has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Stocks similar to Oncorus
Oncorus in the news
Oncorus: Shares Look Cheap As First Oncolytic Viral Therapy Enters Clinic
Here's Why We're Not Too Worried About Oncorus' (NASDAQ:ONCR) Cash Burn Situation
Frequently asked questionsWhat percentage of Oncorus is owned by insiders or institutions?
Currently 1.571% of Oncorus shares are held by insiders and 78.095% by institutions. How many people work for Oncorus?
Latest data suggests 56 work at Oncorus. When does the fiscal year end for Oncorus?
Oncorus's fiscal year ends in December. Where is Oncorus based?
Oncorus's address is: 50 Hampshire Street, Cambridge, MA, United States, 02139 What is Oncorus's ISIN number?
Oncorus's international securities identification number is: US68236R1032
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert